Breaking News, Promotions & Moves

Braveheart Bio Promotes CSO, Names New SVP

Marc Evanchik will be elevated to Chief Scientific Officer, while Brittany de Temple joins as Senior Vice President of Development Operations.

Author Image

By: Patrick Lavery

Content Marketing Editor

Braveheart Bio is naming Marc Evanchik Chief Scientific Officer (CSO) and appointing Brittany de Temple Senior Vice President (SVP). de Temple is joining the clinical-stage biotechnology company as SVP of Development Operations. Evanchik was previously Braveheart Bio’s SVP of Pharmacology and Translational Medicine. In announcing these moves, the company said they advance its capabilities in preparation of initiating a Phase III clinical trial. This global trial concerns BHB-1893, a next-g...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters